REPORT ID 13890

EMEA (Europe, Middle East and Africa) Urolithiasis Management Devices Market Report 2017

Publish Date
22-Nov-17
Pages
117
Format
Electronic (PDF)

In this report, the EMEA Urolithiasis Management Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Urolithiasis Management Devices for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Urolithiasis Management Devices market competition by top manufacturers/players, with Urolithiasis Management Devices sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Allengers Medical Systems Ltd.
    Boston Scientific Corporation
    C.R. Bard, Inc.
    Cook Medical
    ConMed Corporation
    DirexGroup
    Dornier MedTech GmbH
    Guangzhou Potent Optotronic Technology Co., Ltd.
    HealthTronics, Inc.
    Karl Storz GmbH & Co. KG
    Lumenis
    Olympus Corporation
    Richard Wolf
    Siemens Healthcare

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Extracorporeal Shock Wave Lithotripsy (Eswl)
    Intracorporeal Lithotripsy
    Percutaneous Nephrolithotomy
    Other Treatments

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Urolithiasis Management Devices for each application, including
    Hospitals & Clinics
    Ambulatory Surgical Centers

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Urolithiasis Management Devices Market Report 2017
1 Urolithiasis Management Devices Overview
    1.1 Product Overview and Scope of Urolithiasis Management Devices
    1.2 Classification of Urolithiasis Management Devices
        1.2.1 EMEA Urolithiasis Management Devices Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Urolithiasis Management Devices Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Extracorporeal Shock Wave Lithotripsy (Eswl)
        1.2.4 Intracorporeal Lithotripsy
        1.2.5 Percutaneous Nephrolithotomy
        1.2.6 Other Treatments
    1.3 EMEA Urolithiasis Management Devices Market by Application/End Users
        1.3.1 EMEA Urolithiasis Management Devices Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospitals & Clinics
        1.3.3 Ambulatory Surgical Centers
    1.4 EMEA Urolithiasis Management Devices Market by Region
        1.4.1 EMEA Urolithiasis Management Devices Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Urolithiasis Management Devices (2012-2022)
        1.5.1 EMEA Urolithiasis Management Devices Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Urolithiasis Management Devices Revenue and Growth Rate (2012-2022)

2 EMEA Urolithiasis Management Devices Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Urolithiasis Management Devices Market Competition by Players/Manufacturers
        2.1.1 EMEA Urolithiasis Management Devices Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Urolithiasis Management Devices Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Urolithiasis Management Devices Sale Price by Players (2012-2017)
    2.2 EMEA Urolithiasis Management Devices (Volume and Value) by Type/Product Category
        2.2.1 EMEA Urolithiasis Management Devices Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Urolithiasis Management Devices Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Urolithiasis Management Devices Sale Price by Type (2012-2017)
    2.3 EMEA Urolithiasis Management Devices (Volume) by Application
    2.4 EMEA Urolithiasis Management Devices (Volume and Value) by Region
        2.4.1 EMEA Urolithiasis Management Devices Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Urolithiasis Management Devices Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Urolithiasis Management Devices Sales Price by Region (2012-2017)

3 Europe Urolithiasis Management Devices (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Urolithiasis Management Devices Sales and Value (2012-2017)
        3.1.1 Europe Urolithiasis Management Devices Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Urolithiasis Management Devices Revenue and Growth Rate (2012-2017)
    3.2 Europe Urolithiasis Management Devices Sales and Market Share by Type
    3.3 Europe Urolithiasis Management Devices Sales and Market Share by Application
    3.4 Europe Urolithiasis Management Devices Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Urolithiasis Management Devices Sales Volume by Countries (2012-2017)
        3.4.2 Europe Urolithiasis Management Devices Revenue by Countries (2012-2017)
        3.4.3 Germany Urolithiasis Management Devices Sales and Growth Rate (2012-2017)
        3.4.4 France Urolithiasis Management Devices Sales and Growth Rate (2012-2017)
        3.4.5 UK Urolithiasis Management Devices Sales and Growth Rate (2012-2017)
        3.4.6 Russia Urolithiasis Management Devices Sales and Growth Rate (2012-2017)
        3.4.7 Italy Urolithiasis Management Devices Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Urolithiasis Management Devices Sales and Growth Rate (2012-2017)

4 Middle East Urolithiasis Management Devices (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Urolithiasis Management Devices Sales and Value (2012-2017)
        4.1.1 Middle East Urolithiasis Management Devices Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Urolithiasis Management Devices Revenue and Growth Rate (2012-2017)
    4.2 Middle East Urolithiasis Management Devices Sales and Market Share by Type
    4.3 Middle East Urolithiasis Management Devices Sales and Market Share by Application
    4.4 Middle East Urolithiasis Management Devices Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Urolithiasis Management Devices Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Urolithiasis Management Devices Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Urolithiasis Management Devices Sales and Growth Rate (2012-2017)
        4.4.4 Israel Urolithiasis Management Devices Sales and Growth Rate (2012-2017)
        4.4.5 UAE Urolithiasis Management Devices Sales and Growth Rate (2012-2017)
        4.4.6 Iran Urolithiasis Management Devices Sales and Growth Rate (2012-2017)

5 Africa Urolithiasis Management Devices (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Urolithiasis Management Devices Sales and Value (2012-2017)
        5.1.1 Africa Urolithiasis Management Devices Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Urolithiasis Management Devices Revenue and Growth Rate (2012-2017)
    5.2 Africa Urolithiasis Management Devices Sales and Market Share by Type
    5.3 Africa Urolithiasis Management Devices Sales and Market Share by Application
    5.4 Africa Urolithiasis Management Devices Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Urolithiasis Management Devices Sales Volume by Countries (2012-2017)
        5.4.2 Africa Urolithiasis Management Devices Revenue by Countries (2012-2017)
        5.4.3 South Africa Urolithiasis Management Devices Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Urolithiasis Management Devices Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Urolithiasis Management Devices Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Urolithiasis Management Devices Sales and Growth Rate (2012-2017)

6 EMEA Urolithiasis Management Devices Manufacturers/Players Profiles and Sales Data
    6.1 Allengers Medical Systems Ltd.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Urolithiasis Management Devices Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Allengers Medical Systems Ltd. Urolithiasis Management Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Boston Scientific Corporation
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Urolithiasis Management Devices Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Boston Scientific Corporation Urolithiasis Management Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 C.R. Bard, Inc.
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Urolithiasis Management Devices Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 C.R. Bard, Inc. Urolithiasis Management Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Cook Medical
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Urolithiasis Management Devices Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Cook Medical Urolithiasis Management Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 ConMed Corporation
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Urolithiasis Management Devices Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 ConMed Corporation Urolithiasis Management Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 DirexGroup
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Urolithiasis Management Devices Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 DirexGroup Urolithiasis Management Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Dornier MedTech GmbH
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Urolithiasis Management Devices Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Dornier MedTech GmbH Urolithiasis Management Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Guangzhou Potent Optotronic Technology Co., Ltd.
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Urolithiasis Management Devices Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Guangzhou Potent Optotronic Technology Co., Ltd. Urolithiasis Management Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 HealthTronics, Inc.
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Urolithiasis Management Devices Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 HealthTronics, Inc. Urolithiasis Management Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Karl Storz GmbH & Co. KG
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Urolithiasis Management Devices Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Karl Storz GmbH & Co. KG Urolithiasis Management Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Lumenis
    6.12 Olympus Corporation
    6.13 Richard Wolf
    6.14 Siemens Healthcare

7 Urolithiasis Management Devices Manufacturing Cost Analysis
    7.1 Urolithiasis Management Devices Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Urolithiasis Management Devices

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Urolithiasis Management Devices Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Urolithiasis Management Devices Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Urolithiasis Management Devices Market Forecast (2017-2022)
    11.1 EMEA Urolithiasis Management Devices Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Urolithiasis Management Devices Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Urolithiasis Management Devices Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Urolithiasis Management Devices Price and Trend Forecast (2017-2022)
    11.2 EMEA Urolithiasis Management Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Urolithiasis Management Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Urolithiasis Management Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Urolithiasis Management Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Urolithiasis Management Devices Sales Forecast by Type (2017-2022)
    11.7 EMEA Urolithiasis Management Devices Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer